University of Iowa Hospitals & Clinics announces adoption of Accelerate Pheno

Jan 16, 2019

University of Iowa Hospitals & Clinics, USA recently shared their adoption of the Accelerate Pheno™ system as a “new technology that helps diagnose and treat sepsis—a potentially life-threatening infection in the blood—faster than ever before.”

Get the full story from UI Health Care

Quick story excerpt:

“Every hour counts,” explains Bradley Ford, MD, PhD, medical director of the UI Carver College of Medicine Clinical Microbiology Unit and UI principal investigator of a clinical trial of the device. “Traditional testing is growth-based and takes one to three days after the culture turns positive to return a result. This typically means that patients get more drugs, and more broad-spectrum drugs for longer than they would ideally need.”

With the new FDA approved technology, the same data can be generated in six hours in most cases. Most often this means that patients can receive narrower, targeted therapy, but may also catch cases of unexpected antibiotic resistance faster. Waiting less time for results means that patients are likely to return home sooner.

Bradley Ford, MD, PhD and Callie Ostwonkle, BS, MLS, medical laboratory scientist in pathology, work on the Accelerate Pheno system – image by UI Health Care